CIK 0001069530
- Non-accelerated filer
- Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911911336
- Phone
- +1 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other acquisition Chief Financial Officer acquired 4,346 shares (other)
- 4 Other acquisition Chief Operating Officer acquired 3,622 shares (other)
- 4 Grant or award CEO, Chairman of the Board acquired 45,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 11,032 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 10,000 shares (grant or award)
- 4 Other acquisition Chief Operating Officer acquired 596 shares (other)
- 4 Other acquisition Chief Financial Officer acquired 192 shares (other)
- 4 Open-market sale Chief Operating Officer sold 25,000 shares at $4.44 ($111,008)
- 4 Open-market sale 10% owner sold 382,000 shares at an average $4.59 ($1,754,072)
- 4 Open-market sale Chief Operating Officer sold 25,000 shares at an average $4.81 ($120,301)
- 4 Open-market sale Chief Operating Officer sold 25,000 shares at $4.89 ($122,125)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 13 of 30 · 591 filings